Molecular diagnosis of Fragile X syndrome

References

• Crawford DC, Acuna JM, Sherman SL. FMR1 and the Fragile X syndrome: human genome epidemiology review. Genet. Med.3, 359–371 (2001).
   PubMed Web of Science ®Google Scholar
• Garber KB, Visootsak J, Warren ST. Fragile X syndrome. Eur. J. Hum. Genet.16(6), 666–672 (2008).
   PubMed Web of Science ®Google Scholar
• Jacky PB, Ahuja YR, Anyane-Yeboa K et al. Guidelines for the preparation and analysis of the Fragile X chromosome in lymphocytes. Am. J. Med. Genet.38(2–3), 400–403 (1991).
   Google Scholar
• Verkerk AJ, Pieretti M, Sutcliffe JS et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in Fragile X syndrome. Cell65, 905–914 (1991).
   PubMed Web of Science ®Google Scholar
• Yu S, Pritchard M, Kremer E et al. Fragile X genotype characterized by an unstable region of DNA. Science24, 1179–1181 (1991).
   Google Scholar
• Sutherland GR, Baker E. The common Fragile site in band q27 of the human X chromosome is not coincident with the Fragile-X. Clin. Genet.37, 167 (1990).
   Google Scholar
• Knight SJ, Flannery AV, Hirst MC et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental-retardation. Cell74, 127–134 (1993).
   PubMedGoogle Scholar
• Verheij C, Bakker CE, de Graaff E et al. Characterization and localization of the FMR-1 gene product associated with Fragile X syndrome. Nature363(6431), 722–724 (1993).
   PubMed Web of Science ®Google Scholar
• Brown WT, Houck GE Jr, Jeziorowska A et al. Rapid Fragile X carrier screening and prenatal-diagnosis using a non-radioactive PCR test. JAMA270, 1569–1575 (1993).
   Web of Science ®Google Scholar
• Fu YH, Kuhl DP, Pizzuti A et al. Variation of the CGG repeat at the Fragile X site results in genetic instability: resolution of the Sherman paradox. Cell67, 1047–1058 (1991).
   PubMed Web of Science ®Google Scholar
• Nolin SL, Glicksman A, Houck GE Jr, Brown WT, Dobkin CS. Mosaicism in Fragile X affected males. Am. J. Med. Genet.51(4), 509–512 (1994).
   PubMed Web of Science ®Google Scholar
• Zhong N, Ju W, Pietrofesa J, Wang D, Dobkin C, Brown WT. Fragile X “gray zone” alleles: AGG patterns, expansion risks, and associated haplotypes. Am. J. Med. Genet.64(2), 261–265 (1996).
   Google Scholar
• McConkie-Rosell A, Finucane B, Cronister A, Abrams L, Bennett RL, Pettersen BJ. Genetic counseling for Fragile X syndrome: updated recommendations of the national society of genetic counselors. J. Genet. Couns.14, 249–270 (2005).
   PubMedGoogle Scholar
• Nolin SL, Brown TW, Glicksman A et al. Expansion of the Fragile X CGG repeat in females with premutation or intermediate alleles. Am. J. Hum. Genet.72, 454–464 (2003).
   PubMed Web of Science ®Google Scholar
• Sofocleous C, Kitsiou S, Fryssira H et al. 10 years’ experience in Fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach. In Vivo22(4), 451–455 (2008).
   Google Scholar
• Pieretti M, Zhang F, Fu YH et al. Absence of expression of the FMR1 gene in Fragile X syndrome. Cell66, 817–822 (1991).
   PubMed Web of Science ®Google Scholar
• Coffee B, Ikeda M, Budimirovic DB, Hjelm LN, Kaufmann WE, Warren ST. Mosaic FMR1 deletion causes Fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature. Am. J. Med. Genet. A.146A(10), 1358–1367 (2008).
   PubMed Web of Science ®Google Scholar
• Bear MF, Huber KM, Warren ST. The mGluR theory of Fragile X mental retardation. Trends. Neurosci.27, 370–377 (2004).
   PubMed Web of Science ®Google Scholar
• Johnston C, Eliez S, Dyer-Friedman J et al. Neurobehavioral phenotype in carriers of the Fragile X premutation. Am. J. Med. Genet.103, 314–319 (2001).
   Google Scholar
• Wittenberger MD, Hagerman RJ, Sherman SL et al. The FMR1 premutation and reproduction. Fertil. Steril.87, 456–465 (2007).
   PubMed Web of Science ®Google Scholar
• Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. Fragile-X syndrome and Fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol.6, 45–55 (2007).
   PubMed Web of Science ®Google Scholar
• Hagerman PJ, Hagerman RJ. The Fragile-X premutation: a maturing perspective. Am. J. Hum. Genet.74(5), 805–816 (2004).
   PubMed Web of Science ®Google Scholar
• Rousseau F, Heitz D, Biancalana V et al. Direct diagnosis by DNA analysis of the Fragile X syndrome of mental retardation. N. Engl. J. Med.325, 1673–1681 (1991).
   PubMed Web of Science ®Google Scholar
• Rousseau F, Heitz D, Tarleton J et al. A multicenter study on genotype-phenotype correlations in the Fragile X syndrome, using direct diagnosis with probe StB 12.3: the first 2,253 cases. Am. J. Hum. Genet.55, 225–237 (1994).
   PubMed Web of Science ®Google Scholar
• Nolin SL, Ding XH, Houck GE, Brown WT, Dobkin C. Fragile X full mutation alleles composed of few alleles: implications for CGG repeat expansion. Am. J. Med. Genet. A.146A(1), 60–65. (2008).
   Google Scholar
• Pergolizzi RG, Erster SH, Goonewardena P, Brown WT. Detection of full Fragile X mutation. Lancet339, 271–272 (1992)
   Google Scholar
• Houdayer C, Lemonnier A, Gerard M et al. Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus. Clin. Chem. Lab. Med.37, 397–402 (1999).
   PubMed Web of Science ®Google Scholar
• Saluto A, Brussino A, Tassone F et al. An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the Fragile X mental retardation 1 gene. J. Mol. Diagn.7, 605–612 (2005).
   PubMed Web of Science ®Google Scholar
• Haddad LA, Mingroni-Netto RC, Vianna-Morgante AM, Pena SD. A PCR-based test suitable for screening for Fragile X syndrome among mentally retarded males. Hum. Genet.97, 808–812 (1996).
   PubMed Web of Science ®Google Scholar
• Wang Q, Green E, Bobrow M, Mathew CG. A rapid, non-radioactive screening test for Fragile X mutations at the FRAXA and FRAXE loci. J. Med. Gene.32, 170–173 (1995).
   Google Scholar
• Tassone F, Pan R, Amiri K, Taylor AK, Hagerman JP. Rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the Fragile X (FMR1) gene in newborn and high-risk populations. J. Mol. Diagn.10, 43–49 (2008).
   PubMed Web of Science ®Google Scholar
• Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res.22, 2990–2997 (1994).
   PubMed Web of Science ®Google Scholar
• Panagopoulos I, Lassen C, Kristoffersson U, Aman P. A methylation PCR approach for detection of Fragile X syndrome. Hum. Mutat.14, 71–79 (1999).
   PubMedGoogle Scholar
• Zhou Y, Law HY, Boehm CD et al. Robust Fragile X (CGG)n genotype classification using a methylation specific triple PCR assay. J. Med. Genet.41, 45 (2004).
   PubMed Web of Science ®Google Scholar
• Boyd VL, Moody KI, Karger AE, Livak KJ, Zon G, Burns JW. Methylation-dependent fragment separation: direct detection of DNA methylation by capillary electrophoresis of PCR products from bisulfite-converted genomic DNA. Anal. Biochem.354, 266–273 (2006).
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lum JM, Yeo GH, Kiing J, Tay SK, Chong SS. Simplified molecular diagnosis of Fragile X syndrome by fluorescent methylation-specific PCR and GeneScan analysis. Clin. Chem.52, 1492–1500 (2006).
   PubMedGoogle Scholar
• Dahl C, Grønskov K, Larsen LA, Guldberg P, Brøndum-Nielsen K. A homogeneous assay for analysis of FMR1 promoter methylation in patients with Fragile X syndrome. Clin. Chem.53, 790–793 (2007).
   PubMed Web of Science ®Google Scholar
• Dahl C, Guldberg P. DNA methylation analysis techniques. Biogerontology4, 233–250 (2003).
   PubMed Web of Science ®Google Scholar
• Dahl C, Guldberg P. A ligation assay for multiplex analysis of CpG methylation using bisulfite-treated DNA. Nucleic Acids Res.35(21), e144 (2007).
   Google Scholar
• Nygren AO, Lens SI, Carvalho R. Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles. J. Mol. Diagn.10(6), 496–501 (2008).
   PubMed Web of Science ®Google Scholar
• Willemsen R, Mohkamsing S, de Vries B et al. Rapid antibody test for Fragile X syndrome. Lancet345, 1147–1148 (1995).
   PubMedGoogle Scholar
• De Vries BBA, Mohkamsing S, van den Ouweland AMW et al. Screening with the FMR1 protein test among mentally retarded males. Hum. Genet.103, 520–522 (1998).
   Google Scholar
• Willemsen R, Oosterwijk JC, Los FJ, Galjaard H, Oostra BA. Prenatal diagnosis of Fragile X syndrome. Lancet348, 967–968 (1996).
   Google Scholar
• Willemsen R, Los F, Mohkamsing S et al. Rapid antibody test for prenatal diagnosis of Fragile X syndrome on amniotic fluid cells: a new appraisal. J. Med. Genet.3, 250–251 (1997).
   Google Scholar
• Willemsen R , Anar B, De Diego Otero Y et al. Non-invasive test for Fragile X syndrome, using hair root analysis. Am. J. Hum. Genet.65, 98–103 (1999).
   Google Scholar
• Willemsen R, Bontekoe CJ, Severijnen LA, Oostra BA. Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum. Genet.110, 601–605 (2002).
   PubMedGoogle Scholar
• Malcov M, Naiman T, Yosef DB et al. Preimplantation genetic diagnosis for Fragile X syndrome using multiplex nested PCR. Reprod. Biomed. Online14(4), 515–521 (2007).
   Google Scholar
• Wittenberger MD, Hagerman RJ, Sherman SL et al. The FMR1 premutation and reproduction. Fertil. Steril.87(3), 456–465 (2007).
   PubMed Web of Science ®Google Scholar
• Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. Elevated levels of FMR1 messenger RNA in carrier males: increased mRNA in Fragile X Males 235 new mechanism of involvement in the Fragile X syndrome. Am. J. Hum. Genet.66, 6–15 (2000).
   PubMed Web of Science ®Google Scholar
• Kenneson A, Zhang F, Hagedorn CH, Warren ST. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and permutation carriers. Hum. Mol. Genet.10, 1449–1454 (2001).
   PubMed Web of Science ®Google Scholar
• Mínguez M, Ibáñez B, Ribate MP et al. Risk of cognitive impairment in female premutation carriers of Fragile X premutation: analysis by means of robust segmented linear regression models. Am. J. Med. Genet. B. Neuropsychiatr. Genet. (2008) (Epub ahead of print).
   Google Scholar
• Greco C, Hagerman RJ, Tassone F et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxiasyndrome among Fragile X carriers. Brain125, 1760–1771 (2002).
   PubMed Web of Science ®Google Scholar
• Hagerman PJ, Hagerman RJ. The Fragile-X premutation: a maturing perspective. Am. J. Hum. Genet.74(5), 805–816 (2004).
   PubMed Web of Science ®Google Scholar
• Greco CM, Berman RF, Martin RM et al. Neuropathology of Fragile X-associated tremor/ataxia syndrome (FXTAS). Brain129(Pt 1), 243–255 (2006).
   PubMed Web of Science ®Google Scholar
• Brown V, Jin P, Ceman S et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in Fragile X syndrome. Cell107(4), 477–487 (2001).
   PubMed Web of Science ®Google Scholar
• Bittel DC, Kibiryeva N, Butler MG. Whole genome microarray analysis of gene expression in subjects with Fragile X syndrome. Genet. Med.9 (7), 464–472 (2007).
   Web of Science ®Google Scholar
• Larsen LA, Grønskov K, Nørgaard-Pedersen B, Brøndum-Nielsen K, Hasholt L, Vuust J. High-throughput analysis of Fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis. Hum. Genet.100, 564–568 (1997).
   Google Scholar
• Hecimovic S, Vlasic J, Barisic L, Markovic D, Culic V, Pavelic K. A simple and rapid analysis of triplet repeat diseases by expand long PCR. Clin. Chem. Lab. Med.39, 1259–1262 (2001).
   PubMed Web of Science ®Google Scholar
• O’Connell CD, Atha DH, Jakupciak JP, Amos JA, Richie K. Standardization of PCR amplification for Fragile X trinucleotide repeat measurements. Clin. Genet.61, 13–20 (2002).
   PubMed Web of Science ®Google Scholar
• Strom CM, Huang D, Li Y et al. Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome. Genet. Med.9, 199–207 (2007).
   PubMed Web of Science ®Google Scholar
• Pesso R, Berkenstadt M, Cuckle H et al. Screening for Fragile X syndrome in women of reproductive age. Prenat. Diagn.20, 611–614 (2000).
   PubMedGoogle Scholar
• Toledano-Alhadef H, Basel-Vanagaite L, Magal N et al. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am. J. Hum. Genet.69, 351–360 (2001).
   PubMed Web of Science ®Google Scholar
• Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene–and implications for the population genetics of the Fragile X syndrome. Am. J. Hum. Genet.57, 1006–1018 (1995).
   PubMed Web of Science ®Google Scholar
• Ryynanen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K. Feasibility and acceptance of screening for Fragile X mutations in low-risk pregnancies. Eur. J. Hum. Genet.7, 212–216 (1999).
   Google Scholar
• Ibarreta D, Elles R, Cassiman JJ, Rodriquez-Cerezo E, Dequeker E. Towards quality assurance and harmonization of genetic testing services in the European Union. Nat. Biotechnol.22, 1230–1235 (2004).
   PubMed Web of Science ®Google Scholar
• Knight SJ, Regan R, Nicod A et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet354(9191), 1676–1681 (1999).
   PubMed Web of Science ®Google Scholar
• Ahn JW, Mann K, Docherty Z, Mackie Ogilvie C. Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis. Mol. Cytogenet.1(1), 2 (2008).
   Google Scholar
• Madrigal I, Rodríguez-Revenga L, Badenas C et al. MLPA as first screening method for the detection of microduplications and microdeletions in patients with X-linked mental retardation. Genet. Med.9(2), 117–122 (2007).
   Google Scholar
• Froyen G, Van Esch H, Bauters M et al. Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes. Hum. Mutat.28(10), 1034–1042 (2007).
   Web of Science ®Google Scholar
• Falbo V, Floridia G, Tosto F et al. The Italian External Quality Assessment scheme for Fragile X syndrome: the results of a 5-year survey. Genet. Test.12(2), 279–288 (2008).
   Google Scholar
• Wilson AJ, Pratt MV, Phansalkar A et al. Consensus characterization of 16 FMR1 reference materials: a consortium study J. Mol. Diagn.10(1), 2–12 (2008).
   Google Scholar
• Irizarry RA, Ladd-Acosta C, Carvalho B et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome. Res.18(5), 780–790 (2008).
   PubMed Web of Science ®Google Scholar
• Bardoni B, Davidovic L, Bensaid M, Khandjian EW. The Fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev. Mol. Med.8(8), 1–16 (2006).
   PubMedGoogle Scholar